AAAAAA

   
Results: 1-18 |
Results: 18
Immunosuppressive therapy and post-transplantation diarrhea
Authors: Pescovitz, MD Navarro, MT
Citation: Md. Pescovitz et Mt. Navarro, Immunosuppressive therapy and post-transplantation diarrhea, CLIN TRANSP, 15, 2001, pp. 23-28
Differential influence of azathioprine and mycophenolate mofetil on the disposition of basiliximab in renal transplant patients
Authors: Kovarik, JM Pescovitz, MD Sollinger, HW Kaplan, B Legendre, C Salmela, K Book, BK Gerbeau, C Girault, D Somberg, K
Citation: Jm. Kovarik et al., Differential influence of azathioprine and mycophenolate mofetil on the disposition of basiliximab in renal transplant patients, CLIN TRANSP, 15(2), 2001, pp. 123-130
Sirolimus and mycophenolate mofetil for calcineurin-free immunosuppressionin renal transplant recipients
Authors: Pescovitz, MD Govani, M
Citation: Md. Pescovitz et M. Govani, Sirolimus and mycophenolate mofetil for calcineurin-free immunosuppressionin renal transplant recipients, AM J KIDNEY, 38(4), 2001, pp. S16-S21
Overview of the Third International Workshop on Swine Leukocyte Differentiation Antigens
Authors: Haverson, K Saalmuller, A Alvarez, B Alonso, F Bailey, M Bianchi, ATJ Boersma, WJA Chen, Z Davis, WC Dominguez, J Engelhardt, H Ezquerra, A Grosmaire, LS Hamilton, MJ Hollemweguer, E Huang, CA Khanna, KV Kuebart, G Lackovic, G Ledbetter, JA Lee, R Llanes, D Lunney, JK McCullough, KC Molitor, T Nielsen, J Niewold, TA Pescovitz, MD de la Lastra, JP Rehakova, Z Salmon, H Schnitzlein, WM Seebach, J Simon, A Sinkora, J Sinkora, M Stokes, CR Summerfield, A Sver, L Thacker, E Valpotic, I Yang, H Zuckermann, FA Zwart, R
Citation: K. Haverson et al., Overview of the Third International Workshop on Swine Leukocyte Differentiation Antigens, VET IMMUNOL, 80(1-2), 2001, pp. 5-23
Analysis of monoclonal antibodies reacting with molecules expressed on gamma delta T-cells
Authors: Davis, WC Haverson, K Saalmuller, A Yang, H Lunney, JK Hamilton, MJ Pescovitz, MD
Citation: Wc. Davis et al., Analysis of monoclonal antibodies reacting with molecules expressed on gamma delta T-cells, VET IMMUNOL, 80(1-2), 2001, pp. 53-62
Solid-phase HLA antibody detection methods and risk of renal allograft rejection in children
Authors: Book, BK Agrawal, P Dalla Vecchia, LK Gebel, HM Pescovitz, MD Tambur, AR
Citation: Bk. Book et al., Solid-phase HLA antibody detection methods and risk of renal allograft rejection in children, TRANSPLAN P, 33(1-2), 2001, pp. 403-404
Effect of mycophenolate mofetil on the anti-CMV serologic response after renal transplantation
Authors: Hardwick, LL Savatta, SG Book, BK Milgrom, ML McQueen, J Anderson, M Filo, RS Leapman, SB Pescovitz, MD
Citation: Ll. Hardwick et al., Effect of mycophenolate mofetil on the anti-CMV serologic response after renal transplantation, TRANSPLAN P, 33(1-2), 2001, pp. 1865-1866
Results of 3-year phase III clinical trials with daclizumab prophylaxis for prevention of acute rejection after renal transplantation.
Authors: Bumgardner, GL Hardie, I Johnson, RWG Lin, A Nashan, B Pescovitz, MD Ramos, E Vincenti, F
Citation: Gl. Bumgardner et al., Results of 3-year phase III clinical trials with daclizumab prophylaxis for prevention of acute rejection after renal transplantation., TRANSPLANT, 72(5), 2001, pp. 839-845
Valganciclovir - A viewpoint by Mark D. Pescovitz
Authors: Pescovitz, MD
Citation: Md. Pescovitz, Valganciclovir - A viewpoint by Mark D. Pescovitz, DRUGS, 61(8), 2001, pp. 1151-1152
Intravenous mycophenolate mofetil: safety, tolerability, and pharmacokinetics
Authors: Pescovitz, MD Conti, D Dunn, J Gonwa, T Halloran, P Sollinger, H Tomlanovich, S Weinstein, S Inokuchi, S Kiberd, B Kittur, D Merion, RM Norman, D Shoker, A Wilburn, R Nicholls, AJ Arterburn, S Dumont, E
Citation: Md. Pescovitz et al., Intravenous mycophenolate mofetil: safety, tolerability, and pharmacokinetics, CLIN TRANSP, 14(3), 2000, pp. 179-188
Valganciclovir results in improved oral absorption of ganciclovir in livertransplant recipients
Authors: Pescovitz, MD Rabkin, J Merion, RM Paya, CV Pirsch, J Freeman, RB O'Grady, J Robinson, C To, Z Wren, K Banken, L Buhles, W Brown, F
Citation: Md. Pescovitz et al., Valganciclovir results in improved oral absorption of ganciclovir in livertransplant recipients, ANTIM AG CH, 44(10), 2000, pp. 2811-2815
Mycophenolate mofetil in cadaveric renal transplantation
Authors: Cho, S Danovitch, G Deierhoi, M Ferguson, R Gonwa, T Hodge, E Johnson, C Miller, J Neylan, JL Norman, D Pescovitz, MD Sollinger, HW Tomlanovich, SJ Weinstein, S Wang, W Rees, MM Ramos, E
Citation: S. Cho et al., Mycophenolate mofetil in cadaveric renal transplantation, AM J KIDNEY, 34(2), 1999, pp. 296-303
Daclizumab rapidly saturates interleukin-2 receptor-alpha (CD25) on lymph node lymphocytes in children
Authors: Savo, AM Book, BK Henson, S Hakimi, J Pescovitz, MD
Citation: Am. Savo et al., Daclizumab rapidly saturates interleukin-2 receptor-alpha (CD25) on lymph node lymphocytes in children, TRANSPLAN P, 31(1-2), 1999, pp. 1182-1183
New usage paradigms in antibody therapy: Safety of the new agents
Authors: Pescovitz, MD
Citation: Md. Pescovitz, New usage paradigms in antibody therapy: Safety of the new agents, TRANSPLAN P, 31(1-2), 1999, pp. 1201-1202
Cytomegalovirus infections after treatment with daclizumab, an anti IL-2 receptor antibody, for prevention of renal allograft rejection
Authors: Hengster, P Pescovitz, MD Hyatt, D Margreiter, R
Citation: P. Hengster et al., Cytomegalovirus infections after treatment with daclizumab, an anti IL-2 receptor antibody, for prevention of renal allograft rejection, TRANSPLANT, 68(2), 1999, pp. 310-313
Sirolimus reduces the incidence of acute rejection episodes despite lower cyclosporine doses in Caucasian recipients of mismatched primary renal allografts: A phase II trial
Authors: Kahan, BD Julian, BA Pescovitz, MD Vanrenterghem, Y Neylan, J
Citation: Bd. Kahan et al., Sirolimus reduces the incidence of acute rejection episodes despite lower cyclosporine doses in Caucasian recipients of mismatched primary renal allografts: A phase II trial, TRANSPLANT, 68(10), 1999, pp. 1526-1532
Absence of teratogenicity of oral ganciclovir used during early pregnancy in a river transplant recipient
Authors: Pescovitz, MD
Citation: Md. Pescovitz, Absence of teratogenicity of oral ganciclovir used during early pregnancy in a river transplant recipient, TRANSPLANT, 67(5), 1999, pp. 758-759
Bacillary angiomatosis in a renal transplant recipient
Authors: Cline, MS Cummings, OW Goldman, M Filo, RS Pescovitz, MD
Citation: Ms. Cline et al., Bacillary angiomatosis in a renal transplant recipient, TRANSPLANT, 67(2), 1999, pp. 296-298
Risultati: 1-18 |